PACAP is implicated in the stress axes

Current Pharmaceutical Design

Volumn 17, Issue 10, 2011, Pages 985-989

  Hashimoto, Hitoshi ^a,b   Shintani, Norihito ^a   Tanida, Mamoru ^c   Hayata, Atsuko ^a   Hashimoto, Ryota ^a,b   Baba, Akemichi ^a,d  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RITSUMEIKAN UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Hypothalamic pituitary adrenal (HPA) axis; PACAP; Paraventricular nucleus (PVN) of the hypothalamus; Post traumatic disorder (PTSD); Psychiatric disorders; Stress; Sympathetic nervous system; Sympathoadrenomedullary system

Indexed keywords

ADRENALIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VASOPRESSIN;

ADRENAL MEDULLA; ADRENALIN RELEASE; ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BRAIN REGION; CATECHOLAMINE SYNTHESIS; CELLULAR STRESS RESPONSE; CHOLINERGIC SYSTEM; FEAR; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE ENVIRONMENT INTERACTION; HOMEOSTASIS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; METABOLIC STRESS; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; REGULATORY MECHANISM; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYMPATHOADRENOMEDULLARY SYSTEM; VASOPRESSIN RELEASE;

ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 79958164419     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795589382     Document Type: Article

References (52)

1. Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 2001; 22: 502-48.
2. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009; 10: 397-409.
3. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 2005; 67: 259-84.
4. Hashimoto H, Shintani N, Baba A. Higher brain functions of PACAP and a homologous Drosophila memory gene amnesiac: insights from knockouts and mutants. Biochem Biophys Res Commun 2002; 297: 427-31.
5. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567-74.
6. Vaudry D, Falluel-Morel A, Bourgault S, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 2009; 61: 283-357.
7. Sherwood NM, Krueckl SL, McRory JE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000; 21: 619-70.
8. Koves K, Arimura A, Gorcs TG, Somogyvari-Vigh A. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 1991; 54: 159-69.
9. Hannibal J, Mikkelsen JD, Fahrenkrug J, Larsen PJ. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. Endocrinology 1995; 136: 4116-24.
10. Shioda S, Yada T, Nakajo S, Nakaya K, Nakai Y, Arimura A. Pituitary adenylate cyclase-activating polypeptide (PACAP): a novel regulator of vasopressin-containing neurons. Brain Res 1997; 765: 81-90.
11. Dow RC, Bennie J, Fink G. Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat. J Endocrinol 1994; 142: R1-4.
12. Hashimoto H, Nogi H, Mori K, et al. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol 1996; 371: 567-77.
13. Shioda S, Shuto Y, Somogyvari-Vigh A, et al. Localization and gene expression of the receptor for pituitary adenylate cyclaseactivating polypeptide in the rat brain. Neurosci Res 1997; 28: 345-54.
14. Kozicz T, Vigh S, Arimura A. Axon terminals containing PACAPand VIP-immunoreactivity form synapses with CRFimmunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 1997; 767: 109-19.
15. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-9.
16. Usdin TB, Bonner TI, Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994; 135: 2662-80.
17. Das M, Vihlen CS, Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 2007; 500: 761-76.
18. Farnham MM, Li Q, Goodchild AK, Pilowsky PM. PACAP is expressed in sympathoexcitatory bulbospinal C1 neurons of the brain stem and increases sympathetic nerve activity in vivo. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1304-11.
19. Holgert H, Holmberg K, Hannibal J, et al. PACAP in the adrenal gland--relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport 1996; 8: 297-301.
20. Kumar NN, Allen K, Parker L, Damanhuri H, Goodchild AK. Neuropeptide coding of sympathetic preganglionic neurons; focus on adrenally projecting populations. Neuroscience 2010; 170: 789-99.
21. Hamelink C, Tjurmina O, Damadzic R, et al. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci U S A 2002; 99: 461-6.
22. Gray SL, Yamaguchi N, Vencova P, Sherwood NM. Temperaturesensitive phenotype in mice lacking pituitary adenylate cyclaseactivating polypeptide. Endocrinology 2002; 143: 3946-54.
23. Stroth N, Eiden LE. Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience 2010; 165: 1025-30.
24. Tonshoff C, Hemmick L, Evinger MJ. Pituitary adenylate cyclase activating polypeptide (PACAP) regulates expression of catecholamine biosynthetic enzyme genes in bovine adrenal chromaffin cells. J Mol Neurosci 1997; 9: 127-40.
25. Nogi H, Hashimoto H, Hagihara N, et al. Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP), PACAP receptor, vasoactive intestinal polypeptide (VIP), and VIP receptors in the rat superior cervical ganglion. Neurosci Lett 1997; 227: 37-40.
26. Tanida M, Shintani N, Morita Y, et al. Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide. Regul Pept 2010; 161: 73-80.
27. Legradi G, Hannibal J, Lechan RM. Pituitary adenylate cyclaseactivating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat. Neurosci Lett 1998; 246: 145-8.
28. Grinevich V, Fournier A, Pelletier G. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res 1997; 773: 190-6.
29. Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, Coiro V. Effects of intravenously infused pituitary adenylate cyclaseactivating polypeptide on adenohypophyseal Hormone secretion in normal men. Neuroendocrinology 1996; 64: 242-6.
30. Boutillier AL, Monnier D, Koch B, Loeffler JP. Pituitary adenyl cyclase-activating peptide: a hypophysiotropic factor that stimulates proopiomelanocortin gene transcription, and proopiomelanocortin-derived peptide secretion in corticotropic cells. Neuroendocrinology 1994; 60: 493-502.
31. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 1997; 138: 1930-4.
32. Murase T, Kondo K, Otake K, Oiso Y. Pituitary adenylate cyclaseactivating polypeptide stimulates arginine vasopressin release in conscious rats. Neuroendocrinology 1993; 57: 1092-6.
33. Seki Y, Suzuki Y, Baskaya MK, Saito K, Takayasu M, Shibuya M, Sugita K. Central cardiovascular effects induced by intracisternal PACAP in dogs. Am J Physiol 1995; 269: H135-9.
34. Lutz-Bucher B, Monnier D, Koch B. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion. Neuroendocrinology 1996; 64: 153-61.
35. Morita Y, Yanagida D, Shintani N, et al. Lack of trimethyltin (TMT)-induced elevation of plasma corticosterone in PACAPdeficient mice. Ann N Y Acad Sci 2006; 1070: 450-6.
36. Hatanaka M, Tanida M, Shintani N, et al. Lack of light-induced elevation of renal sympathetic nerve activity and plasma corticosterone levels in PACAP-deficient mice. Neurosci Lett 2008; 444: 153-6.
37. Agarwal A, Halvorson LM, Legradi G. Pituitary adenylate cyclaseactivating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res 2005; 138: 45-57.
38. Hammack SE, Cheung J, Rhodes KM, et al. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 2009; 34: 833-43.
39. Hammack SE, Roman CW, Lezak KR, et al. Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediat ing the behavioral consequences of chronic stress. J Mol Neurosci 2010; 42: 327-40.
40. Yaka R, He DY, Phamluong K, Ron D. Pituitary adenylate cyclaseactivating polypeptide (PACAP(1-38) enhances N-methyl-Daspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J Biol Chem 2003; 278: 9630-8.
41. Zink M, Otto C, Zorner B, Zacher C, Schutz G, Henn FA, Gass P. Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor. Neurosci Lett 2004; 360: 106-8.
42. Legradi G, Das M, Giunta B, Hirani K, Mitchell EA, Diamond DM. Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test. Neural Plast 2007; 2007: 79102.
43. Hashimoto H, Shintani N, Tanaka K, et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 2001; 98: 13355-60.
44. Tanaka K, Shintani N, Hashimoto H, et al. Psychostimulantinduced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 2006; 26: 5091-7.
45. Hashimoto H, Hashimoto R, Shintani N, et al. Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J Neurochem 2009; 110: 595-602.
46. Yamada K, Matsuzaki S, Hattori T, et al. Increased stathmin1 expression in the dentate gyrus of mice causes abnormal axonal arborizations. PLoS One 2010; 5: e8596.
47. Hashimoto R, Hashimoto H, Shintani N, et al. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 2007; 12: 1026-32.
48. Hashimoto R, Hashimoto H, Shintani N, et al. Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Neurosci Lett 2010; 468: 300-2.
49. Hattori T, Baba K, Matsuzaki S, et al. A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol Psychiatry 2007; 12: 398-407.
50. Ishihama T, Ago Y, Shintani N, et al. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Behav Brain Res 2010; 209: 274-80.
51. Ressler KJ, Mercer KB, Bradley B, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011; 470: 492-7.
52. Reichenstein M, Rehavi M, Pinhasov A. Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J Mol Neurosci 2008; 36: 330-8.